Ushbu ish iqtibos qilgan ishlar

262 ta ish

Ish: Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

Hallmarks of Cancer: The Next Generation
Douglas Hanahan, Robert A. Weinberg
Sharh maqola201118 iqtibos
ABI
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott +26
Maqola20109 iqtibos
ABI
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail, Johanna A. Joyce
Sharh maqola20136 iqtibos
ABI
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano, Mohanraj Ramachandran, Anna Dimberg
Sharh maqola20196 iqtibos
ABI
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp +2
Sharh maqola20165 iqtibos
ABI
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth
Sharh maqola20115 iqtibos
ABI
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
Nazila Kamaly, Basit Yameen, Jun Wu +1
Sharh maqola20164 iqtibos
ABI
The tumor microenvironment’s role in the response to immune checkpoint blockade
Konstantinos Aliazis, Anthos Christofides, Rushil Shah +4
Sharh maqola20254 iqtibos
ABI
Cancer immunotherapy using checkpoint blockade
Antoni Ribas, Jedd D. Wolchok
Sharh maqola20183 iqtibos
ABI
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp, Michael Kalos, David M. Barrett +10
Maqola20133 iqtibos
ABI
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk, Michalina Janiszewska, Kornélia Polyák
Sharh maqola20203 iqtibos
ABI
Long-term outcomes following CAR T cell therapy: what we know so far
Kathryn M. Cappell, James N. Kochenderfer
Sharh maqola20233 iqtibos
ABI
Therapeutic targeting of the hypoxic tumour microenvironment
Dean C. Singleton, Andrew Macann, William R. Wilson
Sharh maqola20213 iqtibos
ABI
Immune suppressive mechanisms in the tumor microenvironment
David H. Munn, Vincenzo Bronte
Sharh maqola20153 iqtibos
ABI
The Acidic Tumor Microenvironment as a Driver of Cancer
Ebbe Boedtkjer, Stine F. Pedersen
Sharh maqola20193 iqtibos
ABI
Hypoxia-inducible factors: cancer progression and clinical translation
Elizabeth E. Wicks, Gregg L. Semenza
Sharh maqola20223 iqtibos
ABI
Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response
Yuxin Zhang, Zaixiang Fang, Dayi Pan +10
Maqola20243 iqtibos
ABI
pH-Responsive polymers
Gökhan Kocak, Cansel Tuncer, Vural Bütün
Maqola20162 iqtibos
ABI
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer
Karen A. Autio, Robert Dreicer, Justine Anderson +13
Maqola20182 iqtibos
ABI
ATP-triggered anticancer drug delivery
Ran Mo, Tianyue Jiang, Rocco DiSanto +2
Maqola20142 iqtibos
ABI
A Phenylboronate‐Functionalized Polyion Complex Micelle for ATP‐Triggered Release of siRNA
Mitsuru Naito, Takehiko Ishii, Akira Matsumoto +3
Maqola20122 iqtibos
ABI
Acidic pH‐Responsive siRNA Conjugate for Reversible Carrier Stability and Accelerated Endosomal Escape with Reduced IFNα‐Associated Immune Response
Hiroyasu Takemoto, Kanjiro Miyata, Shota Hattori +5
Maqola20132 iqtibos
ABI
ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy
Xiaoding Xu, Phei Er Saw, Wei Tao +9
Maqola20172 iqtibos
ABI
Normalizing Tumor Vessels To Increase the Enzyme-Induced Retention and Targeting of Gold Nanoparticle for Breast Cancer Imaging and Treatment
Wei Xiao, Shaobo Ruan, Wenqi Yu +4
Maqola20172 iqtibos
ABI
Up-Regulation of PD-L1, IDO, and T <sub>regs</sub> in the Melanoma Tumor Microenvironment Is Driven by CD8 <sup>+</sup> T Cells
Stefani Spranger, Robbert M. Spaapen, Yuanyuan Zha +4
Maqola20132 iqtibos
ABI